Classification of drugs for teratogenic risk G. AlvánB. R. DanielssonR. Sannerstedt Special Article Pages: 177 - 178
Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence P. ZanenJ. -W. J. Lammers Clinical Trials Pages: 179 - 184
Recovery characteristics following anaesthesia with sevoflurane or propofol in adults undergoing out-patient surgery C. WandelS. NeffE. Martin Clinical Trials Pages: 185 - 188
Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris K. OginoS. OsakiH. Mashiba Pharmacodynamics Pages: 189 - 194
Pressor, renal and endocrine effects of l-arginine in essential hypertensives R. PedrinelliM. EbelA. Clerico Pharmacodynamics Pages: 195 - 201
Effect of moxonidine on urinary electrolyte excretion and renal haemodynamics in man A. WiecekM. NowickiE. Ritz Pharmacodynamics Pages: 203 - 208
High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate K. SakuB. ZhangK. Arakawa Pharmacodynamics Pages: 209 - 215
Does lowering of cholesterol levels influence functional properties of large arteries? M. KoolH. Struijker BoudierI. Hoogendam Pharmacodynamics Pages: 217 - 223
The characteristics of the inhibition of serum cholinesterase by metoclopramide S. G. GrahamA. W. A. Crossley Pharmacodynamics Pages: 225 - 228
Effect of combined atenolol and nifedipine administration on psychomotor performance in normal subjects L. GerrardN. M. WheeldonD. G. McDevitt Pharmacodynamics Pages: 229 - 233
Effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms E. LunellL. MolanderS. J. Leischow Pharmacodynamics Pages: 235 - 240
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393) P. ThürmannS. HarderC. M. Kirchmaier Pharmacodynamics Pages: 241 - 246
Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers F. O. MüllerR. SchallM. V. Middle Pharmacodynamics Pages: 247 - 251
Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins R. J. HermanA. ChaudharyM. A. Boctor Pharmacokinetics and Disposition Pages: 253 - 258
Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 mg) after repeated administration in healthy volunteers G. BianchettiC. DubrucG. Houin Pharmacokinetics and Disposition Pages: 259 - 264
Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam S. R. BareggiR. PirolaG. Devis Pharmacokinetics and Disposition Pages: 265 - 268
The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man U. BuschG. HeinzelH. Narjes Pharmacokinetics and Disposition Pages: 269 - 272
Pharmacokinetics of 5-aminosalicylic acid from controlled-release capsules in man D. K. YuB. MorrillM. B. Lanman Pharmacokinetics and Disposition Pages: 273 - 277
Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its Phase I and Phase II metabolites M. F. FrommS. BotschJ. Evers Pharmacokinetics and Disposition Pages: 279 - 283
Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis K. K. C. TanJ. A. UttridgeJ. Wallwork Pharmacokinetics and Disposition Pages: 285 - 289
Pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus infection M. C. NahataM. T. Brady Pharmacokinetics and Disposition Pages: 291 - 293
Influence of vitamin C on the absorption and first pass metabolism of propranolol J. P. GonzalezR. CalvoP. du Souich Pharmacokinetics and Disposition Pages: 295 - 297
Changes in the use of antibacterial drugs in the countries of central and eastern Europe R. A. KiivetV. BíbaM. Popova Pharmacoepidemiology and Prescription Pages: 299 - 304
Red cell folate levels in pregnant epileptic women T. TomsonU. LindbomA. Berg Pharmacoepidemiology and Prescription Pages: 305 - 308
Azathioprine toxicity, 6-mercaptopurine accumulation and the “poor” 6-thiopurine methylator phenotype A. EscousseC. SgroD. Chevet Letters to the Editors Pages: 309 - 310
Secondary prevention of myocardial infarction: impact of clinical trials on clinical practice Z. RumboldtI. BožićS. Sardelić Letters to the Editors Pages: 311 - 312
